This legalised discrimination against working class and poor children is happening so wealthy consultants and private healthcare companies can further enrich themselves. Here's the report: https://t.co/mevf4gRFew #LegalisedDiscrimination #HealthInequality #WealthGap #Nospecificcountrycodescanbeidentifiedintheprovidedtweet.
If you’ve money in Ireland your kid can skip hospital waiting lists. But it’s back of the line for kids whose parents don’t have money. As the kids of most journalists & Gov ministers can skip hospital waiting lists, no one in power says a thing about this dystopian system. Fact https://t.co/WZ5D85oElN #HealthInequality #AccessToCare #IrelandHealthcare #IE
In Liverpool, health leaders are addressing the historical neglect of women's healthcare, highlighted by alarming statistics showing that women in the city experience significantly poorer health outcomes and face numerous barriers to care, prompting calls for systemic changes and improved access to services. #WomensHealth #HealthInequality #HealthcareAccess #GB
A recent study indicates that while average height in Great Britain has been rising, particularly during the pandemic, this increase is primarily linked to growing childhood obesity rates, especially among poorer children, rather than improvements in health, highlighting widening socioeconomic disparities. #ChildObesity #HealthInequality #Epidemiology #GB #EU #RU #TR #HU #CY #FI
In Italia, le disuguaglianze nell'accesso alle cure pediatriche compromettono il diritto alla salute dei bambini, rendendo necessario affrontare questo problema non solo come un tema sanitario, ma anche come una questione di responsabilità civile e politica. #ChildHealth #HealthInequality #SocialJustice
Fast die Hälfte der Deutschen im mittleren Lebensalter leidet an zwei oder mehr chronischen Erkrankungen, wobei regionale Unterschiede und Risikofaktoren wie Bewegungsmangel, Rauchen und Alkoholkonsum eine bedeutende Rolle spielen. #ChronicDiseases #Multimorbidity #HealthInequality
An international investigation reveals that Merck's commercial strategy for its cancer drug Keytruda, which costs over R$20,000 in Brazil, employs complex legal and pricing tactics to control access, thereby making it increasingly inaccessible to many patients worldwide, despite its significant role in treating various cancers and generating billions in revenue. #CancerTreatment #PharmaceuticalIndustry #HealthInequality
